Cell Biosciences (Palo Alto, CA) commercial-stage developer of nanoproteomic diagnostic analysis systems, closed a $10M Series C financing. Participants include Wellcome Trust, Domain Associates, Latterell Venture Partners, Novo, Mitsui Ventures, RBC Venture Partners and The Vertical Group.